The Role of Colchicine in Atherosclerosis: From Bench to Bedside
Open Access
- 1 July 2022
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (7) , 1395
Abstract
Inflammation is a key feature of atherosclerosis. The inflammatory process is involved in all stages of disease progression, from the early formation of plaque to its instability and disruption, leading to clinical events. This strongly suggests that the use of anti-inflammatory agents might improve both atherosclerosis progression and cardiovascular outcomes. Colchicine, an alkaloid derived from the flower Colchicum autumnale, has been used for years in the treatment of inflammatory pathologies, including Gout, Mediterranean Fever, and Pericarditis. Colchicine is known to act over microtubules, inducing depolymerization, and over the NLRP3 inflammasome, which might explain its known anti-inflammatory properties. Recent evidence has shown the therapeutic potential of colchicine in the management of atherosclerosis and its complications, with limited adverse effects. In this review, we summarize the current knowledge regarding colchicine mechanisms of action and pharmacokinetics, as well as the available evidence on the use of colchicine for the treatment of coronary artery disease, covering basic, translational, and clinical studies.Keywords
Funding Information
- Comisión Nacional de Investigación Científica y Tecnológica (1210655, ICN2021_004)
- ANID, Programa Iniciativa Científica Milenio (1210655, ICN2021_004)
This publication has 152 references indexed in Scilit:
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasomeCell Death & Disease, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- The InflammasomesCell, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerNature Immunology, 2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low‐dose colchicineBritish Journal of Pharmacology, 2008
- Inflammation in atherosclerosisNature, 2002